Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tarceva and WBRT in NSCLC with Brain Metastases
NCT00554775Phase 2Terminated
- Sponsor
- University College London
- Start
- Jan 2008
- Primary completion
- Nov 2010
- Countries
- 1
01
Overview
A Phase 2 trial of erlotinib in non-small cell lung cancer (NSCLC), brain metastases, sponsored by University College London. Started Jan 2008; status: terminated.
02
Drugs
erlotinib
03
Conditions
non-small cell lung cancer (NSCLC)brain metastases
Beyond the preview
Go deeper on NCT00554775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00554775.